Comorbid Dementia and Cancer Therapy Decision-Making: A Scoping Review

Author:

Halpin Sean N.1ORCID,Alain Gabriel2,Seaman Aaron3,Stevens Erin E.4,Zhao Hui5,Fowler Mackenzie E.6,Zhang Qiuyang7,Cadet Tamara8ORCID,Ye Minzhi9,Krok-Schoen Jessica L.2ORCID

Affiliation:

1. GenOmics and Translational Research Center RTI International, Research Triangle Park, NC, USA

2. School of Health and Rehabilitation Sciences, The Ohio State University College of Medicine, Columbus, OH, USA

3. Department of General Internal Medicine, The University of Iowa, Iowa City, IA, USA

4. Division of Palliative Care, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA

5. School of Nursing, James Madison University, Harrisonburg, VA, USA

6. School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, USA

7. Department of Structural & Cellular Biology, School of Medicine, Tulane University, New Orleans, LA, USA

8. School of Social Policy & Practice, University of Pennsylvania, Boston, MA, USA

9. School of Lifespan Development and Educational Science, Kent State University, Kent, OH, USA

Abstract

Comorbid dementia complicates cancer therapy decision-making in older adults. We aimed to synthesize the recent literature (<5 years) on the challenges associated with cancer therapy decision-making among older people living with dementia (PLWD) and their caregivers. Of the 20,763 references, 8767 had their title and abstract screened, and eight met the inclusion criteria. Six studies were qualitative, one study employed mixed methods, and one study was quasi-experimental. Most studies were conducted in the UK (89%) and reported homogeneity in race and geography. Breast (56%) and prostate (45%) were the most frequent reported cancers. Five studies (56%) reported multiple types of dementia, with two (22%) indicating stages. The studies indicated that communication between patients, caregivers, and clinical teams might alleviate stress caused by worsening health prospects and potential ethical concerns. Information from this review can lead to better-informed, patient-centered treatment decision processes among older PLWD and cancer, their caregivers, and clinicians.

Publisher

SAGE Publications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3